MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. The company is headquartered in San Diego, California and currently employs 28 full-time employees. The company went IPO on 2003-12-18. The firm's treasury initiative is anchored by Litecoin. The firm has discontinued the clinical development of voruciclib, while certain nonclinical activities related to its drug candidate assets continue to be conducted by it. As part of the review of strategic alternatives, the Company may consider options such as out-licensing opportunities for existing programs and merger and acquisition opportunities.
Follow-Up Questions
MEI Pharma Inc (LITS)'in P/E oranı nedir?
MEI Pharma Inc 'in P/E oranı 1.7053 'dir
LITS hissesinin fiyat performansı nasıl?
LITS 'in mevcut fiyatı $1.98 'dir, son işlem günde 5.58% increased etti.
MEI Pharma Inc için ana iş temaları veya sektörler nelerdir?
MEI Pharma Inc Biotechnology endüstrisine ait ve sektör Health Care 'dir
MEI Pharma Inc 'in piyasa değerlemesi nedir?
MEI Pharma Inc 'in mevcut piyasa değerlemesi $70.7M 'dir
